Showing results (101-110 of 223) with videos related to
Sort By:
Pageof 23
Experimental Hematology|July 10, 2012
Gene expression profiling of acute graft-vs-host disease after hematopoietic stem cell transplantationJan Verner, Jitka Kabathova, Alexandra Tomancova, et al.Annals of Hematology|January 11, 2018
The incidence of biopsy-proven transformation in follicular lymphoma in the rituximab era. A retrospective analysis from the Czech Lymphoma Study Group (CLSG) databaseAndrea Janikova, Zbynek Bortlicek, Vit Campr, et al.Plos One|March 27, 2020
CD20 is dispensable for B-cell receptor signaling but is required for proper actin polymerization, adhesion and migration of malignant B cellsVeronika Kozlova, Aneta Ledererova, Adriana Ladungova, et al.Hematological Oncology|August 22, 2013
No clinical evidence for performing trough plasma and intracellular imatinib concentrations monitoring in patients with chronic myelogenous leukaemiaZdenek Racil, Filip Razga, Hana Klamova, et al.Blood|August 3, 2016
Ibrutinib inhibits CD20 upregulation on CLL B cells mediated by the CXCR4/SDF-1 axisGabriela Pavlasova, Marek Borsky, Vaclav Seda, et al.British Journal of Haematology|April 3, 2020
A five-year follow-up of untreated patients with chronic lymphocytic leukaemia treated with ofatumumab and chlorambucil: final analysis of the Complement 1 phase 3 trialFritz Offner, Tadeusz Robak, Ann Janssens, et al.Cancer Genetics and Cytogenetics|January 27, 2009
Inactivation of p53 and amplification of MYCN gene in a terminal lymphoblastic relapse in a chronic lymphocytic leukemia patientKaterina Stano-Kozubik, Jitka Malcikova, Boris Tichy, et al.Haematologica|June 11, 2026
Multicolor detection of chronic myeloid leukemia stem cells, including novel marker CD69, predicts survival and early hematological toxicityMartin Culen, Marianna Romzova, Dagmar Smitalova, et al.Haematologica|April 16, 2013
ATM mutations uniformly lead to ATM dysfunction in chronic lymphocytic leukemia: application of functional test using doxorubicinVeronika Navrkalova, Ludmila Sebejova, Jana Zemanova, et al.Oncotarget|May 5, 2016
Quantitative assessment of the CD26+ leukemic stem cell compartment in chronic myeloid leukemia: patient-subgroups, prognostic impact, and technical aspectsMartin Culen, Marek Borsky, Veronika Nemethova, et al.Pageof 23